Oppenheimer & Co’s CUBIST PHARMACEUTICALS INC CBST Stock Holding History

Oppenheimer & Co’s Portfolio CBST Stock Details CBST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-17,632	Closed	-$1.77M	–	1598
2014 Q4	$1.77M	Buy	17,632 +12,926	+275%	+$1M	0.05%	424
2014 Q3	$312K	Sell	4,706 -14,538	-76%	-$955K	0.01%	1052
2014 Q2	$1.34M	Buy	19,244 +8,601	+81%	+$585K	0.04%	509
2014 Q1	$778K	Sell	10,643 -5,599	-34%	-$417K	0.02%	687
2013 Q4	$1.12M	Buy	+16,242	New	+$1.05M	0.04%	523
2013 Q3	–	Sell	-18,942	Closed	-$915K	–	1416
2013 Q2	$915K	Buy	+18,942	New	+$931K	0.04%	541

Oppenheimer & Co's CBST Position: Q1 2015 in Review

Oppenheimer & Co sold out of CUBIST PHARMACEUTICALS INC (CBST) in Q1 2015, closing a stake of 17,632 shares — an estimated $1.77M sold.

Oppenheimer & Co first reported a position in CBST in Q2 2013 and held it in 6 quarters. The position peaked at $1.77M in Q4 2014. 0 funds tracked by Wall St. Rank hold CBST as of Q1 2015.

Oppenheimer & Co reported no remaining CUBIST PHARMACEUTICALS INC position as of Q1 2015 after selling out during the quarter.
Oppenheimer & Co sold 17,632 CUBIST PHARMACEUTICALS INC shares in Q1 2015, an estimated $1.77M.
Oppenheimer & Co first reported a position in CUBIST PHARMACEUTICALS INC in Q2 2013 and held it in 6 quarters.
Oppenheimer & Co's CUBIST PHARMACEUTICALS INC position peaked at $1.77M in Q4 2014.
0 funds tracked by Wall St. Rank held CUBIST PHARMACEUTICALS INC as of Q1 2015.

Based on Oppenheimer & Co's 13F filing for Q1 2015, filed 8 May 2015.